HealthEquity, Inc.
Every calculator, already run for HQY
Open the full toolkit →You have the numbers on HQY. Get the argument.
A written report on which of these readings actually decide the outcome for HealthEquity, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
15 analysts covering HQYAnalyst Price Target Disagreement for HealthEquity, Inc.
Wall Street's bull case implies +49% from the current price; the bear case implies +10%. A 39% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for HQY
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About HealthEquity, Inc.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct s…
HQY — frequently asked
Is HQY a buy right now?
Wall Street's consensus rating on HealthEquity, Inc. is Strong Buy across 15 analysts, with a mean price target of $119.33 (+25% vs. the current $95.14). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is HQY overvalued?
HQY trades at 34.3x trailing earnings, against a DCF fair value of $187 per share. The current price implies -2% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
What is the analyst price target disagreement for HealthEquity, Inc.?
Analysts covering HealthEquity, Inc. (HQY) range from a bear-case target of $105.00 to a bull-case high of $142.00, with a mean consensus target of $119.33 across 15 analysts. The spread of $37.00 (39% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare HealthEquity, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For HealthEquity, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full HQY research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on HealthEquity, Inc., in minutes. 3 free reports included with every account — no credit card required.